altipres pediatric
Generic: dextromethorphan hbr, guaifenesin, phenylephrine hcl
Labeler: advanced generic corporationDrug Facts
Product Profile
Brand Name
altipres pediatric
Generic Name
dextromethorphan hbr, guaifenesin, phenylephrine hcl
Labeler
advanced generic corporation
Dosage Form
LIQUID
Routes
Active Ingredients
dextromethorphan hydrobromide 5 mg/5mL, guaifenesin 75 mg/5mL, phenylephrine hydrochloride 2.5 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
45737-105
Product ID
45737-105_472eca54-1c0a-770e-e063-6294a90a7e01
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH DRUG
Application Number
M012
Listing Expiration
2026-12-31
Marketing Start
2024-12-01
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
45737105
Hyphenated Format
45737-105
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
altipres pediatric (source: ndc)
Generic Name
dextromethorphan hbr, guaifenesin, phenylephrine hcl (source: ndc)
Application Number
M012 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/5mL
- 75 mg/5mL
- 2.5 mg/5mL
Packaging
- 473 mL in 1 BOTTLE (45737-105-16)
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "472eca54-1c0a-770e-e063-6294a90a7e01", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0345737105162"], "unii": ["9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1119541"], "spl_set_id": ["2a336896-a2f8-2a0c-e063-6294a90ae03a"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Advanced Generic Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (45737-105-16)", "package_ndc": "45737-105-16", "marketing_start_date": "20241201"}], "brand_name": "Altipres Pediatric", "product_id": "45737-105_472eca54-1c0a-770e-e063-6294a90a7e01", "dosage_form": "LIQUID", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "45737-105", "generic_name": "Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl", "labeler_name": "Advanced Generic Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Altipres Pediatric", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "5 mg/5mL"}, {"name": "GUAIFENESIN", "strength": "75 mg/5mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "2.5 mg/5mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20241201", "listing_expiration_date": "20261231"}